Treatment response to bortezomib in multiple myeloma correlates with plasma hepatocyte growth factor concentration and bone marrow thrombospondin concentration. [electronic resource]
Producer: 20100603Description: 332-6 p. digitalISSN:- 1600-0609
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Bone Marrow -- metabolism
- Boronic Acids -- administration & dosage
- Bortezomib
- Female
- Hepatocyte Growth Factor -- blood
- Humans
- Male
- Middle Aged
- Multiple Myeloma -- blood
- Neovascularization, Pathologic -- blood
- Pyrazines -- administration & dosage
- Recurrence
- Thrombospondins -- metabolism
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.